spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

CPhI India 2017

CPhI & P-MEC India 2017

27-30 November 2017
Bombay Exhibition Centre & MMRDA Grounds, BKC

CPhI India 2017 is India's largest and leading pharmaceutical exhibition, which brings together more than1,200 exhibiting companies and over 50,000 pharma industry professionals from 120+ countries. Source new suppliers, network, develop new and existing relationships and do business in pharma - all in one location. CPhI India represents the pharmaceutical ingredients sector and its key players. Exhibitors are divided into different zones on the show floor, helping you to access quality leads that are relevant to your business.

CPhI India 2017, a four day exhibition taking place at two venues, is dedicated to anyone working in active pharmaceutical ingredients (APIs) - providing an opportunity to meet the movers and shakers in India’s pharma ingredients industry for a competitive advantage that will help grow your business

https://ubm.cphi.com/in2017ad/

phone +91 22 6172 7163
email ketki.karkhanis@ubm.com
web https://ubm.cphi.com/in2017ad/
email Mumbai, India
 
Print this page
Send to a friend
   
spacer
Industry Events

Global Bioproduction Summit, 5th-6th February 2018

5-6 February 2018, Hilton San Diego Resort & Spa, CA

After 15 years in Europe, the Global Bioproduction Summit moved to its new home of San Diego in 2016. The Bioproduction Summit delves deep into the world of biological production.
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>


News and Press Releases

New awareness campaign aims to help organisations prepare for GS1


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement